Evidence map›Paper›PMID 42270942›Full record

ArticleCommunications biology2026

Mutation of a conserved lysine in the RdRp fingers domain broadly attenuates orthobunyaviruses.

Guodian Xiong, Fei Wang, Jingjing Tang, Tao Cheng, Nanjie Ren, Jingke Geng, Wei Chen, Doudou Huang, Zengqin Deng, Xiang Sun and 3 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Guodian Xiong *Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.ORCID 0009-0004-1005-1116
Fei Wang *Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Jingjing Tang *Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Tao ChengKey Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Nanjie RenNingbo Prefectural Center for Disease Control and Prevention, Ningbo, China.
Jingke GengKey Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Wei ChenKey Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Doudou HuangKey Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Zengqin DengKey Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.ORCID 0000-0002-5658-2068
Xiang SunXinjiang Military Command Center for Disease Control and Prevention, Xinjiang Uygur Autonomous Region, Urumqi, China.
Jinglin WangYunnan Key Laboratory of Cross-Border Infectious Disease Control and Novel Drug Development (Under construction) & Yunnan Provincial Key Laboratory of Public Health and Biosafety, School of Public Health, Kunming Medical University, Kunming, China. wangjl107@163.com.ORCID 0000-0002-4903-7168
Zhiming YuanKey Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China. yzm@wh.iov.cn.ORCID 0000-0002-3234-9616
Han XiaKey Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China. hanxia@wh.iov.cn.ORCID 0000-0001-9932-6040

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2023YFC2305900National Natural Science Foundation of China (National Science Foundation of China) 32260896National Natural Science Foundation of China (National Science Foundation of China) 82572569
6 · The paper itself

Abstract

Orthobunyaviruses, comprising more than 130 species, constitute a significant threat to human and animal health, yet no effective broad-spectrum treatments or vaccines are currently available. Here, we initially identified an evolutionarily constrained lysine residue, highly conserved across all 22 Orthobunyavirus serogroups, within the α30 helix of the RNA-dependent RNA polymerase (RdRp). Functional interrogation of this site by charge-reversal substitution (K-to-E) substantially impaired polymerase activity and led to marked attenuation of Ebinur Lake virus (EBIV), as evidenced by impaired replication, attenuated cytopathogenicity, and reduced virulence in mice. The similar attenuation observed in Bunyamwera virus (BUNV), the prototype virus of the genus, and Oya virus (OYAV), a member of the Simbu serogroup, demonstrates that this residue fulfills a conserved functional role. Biochemical and cellular analyses further revealed a graded, charge-dependent mutational effect, indicating that attenuation arises predominantly from disruption of the essential interaction between RdRp and the 3' terminus of viral genomic RNA (3' vRNA). Structural modeling and mutagenesis further suggest that the K-to-E substitution creates a new hydrogen bond that may also contribute to viral attenuation. Together, these findings establish the conserved lysine as a critical regulator of RdRp function and offer a rational strategy for broad-spectrum attenuation of orthobunyaviruses.

Indexed as

LysineMutationOrthobunyavirusRNA-Dependent RNA PolymeraseViral ProteinsAmino Acid SequenceAnimalsConserved SequenceHumansMiceVirus ReplicationLysineRNA-Dependent RNA PolymeraseViral Proteins

Identifiers

PMID42270942
PMCPMC13597503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.